跳转至内容
Merck
CN

Anaphylactoid reaction to carboplatin: successful "desensitization".

Allergologia et immunopathologia (2003-12-13)
A Moreno-Ancillo, C Domínguez-Noche, A C Gil-Adrados, P M Cosmes, I Duarte, Y Mateos
摘要

Carboplatin (CP) hypersensitivity reactions have been reported in nearly 12 % of patients treated with this drug. The pathophysiologic mechanisms of these reactions have not been entirely elucidated. Various hypotheses are under discussion. CP hypersensitivity reactions could be IgE-mediated, caused by low-molecular platinum compounds acting as haptens. Platinum salts are also able to release histamine from basophils and mast cells, and some events seem to be non-immune-mediated direct histamine release. We report a case of CP tolerance induction in a 65-year-old man. During the third course of CP he experienced an anaphylactic reaction. Skin testing was negative. Suspecting the possibility of an anaphylactoid reaction due to histamine release, we developed a protocol to induce tolerance. Pre-medication with corticosteroid and antihistaminic was performed before intravenous CP infusion. The bag with CP was first infused 60 ml/h for 30 minutes; the infusion was well tolerated and infusion was continued at 100 ml/h for the next 60 minutes and thereafter at 120 ml/h until the bag was finished. Following this "desensitization", monthly courses of CP using the same protocol have been well tolerated.

材料
产品编号
品牌
产品描述

Supelco
马来酸氯苯那敏, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(±)-氯苯那敏 马来酸盐, ≥99% (perchloric acid titration)
Sigma-Aldrich
S-(+)-Chlorpheniramine maleate salt
Supelco
扑尔敏马来酸盐标准液 马来酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
氯苯那敏, European Pharmacopoeia (EP) Reference Standard
马来酸右氯苯那敏, European Pharmacopoeia (EP) Reference Standard